Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers
Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers SEATTLE --(BUSINESS WIRE)--Aug. 3, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
View HTML
Toggle Summary NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
SEATTLE --(BUSINESS WIRE)--Jul. 8, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2020 financial results after the close of the market on Monday,
View HTML
Toggle Summary NanoString Announces New Products to Advance COVID-19 Disease Research
New nCounter Panels for Viral and Host Response and GeoMx COVID-19 Immune Response Atlas Reveal Novel Insights into SARS-CoV-2 Pathology SEATTLE --(BUSINESS WIRE)--Jun. 16, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational
View HTML
Toggle Summary NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access SEATTLE --(BUSINESS WIRE)--May 20, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a
View HTML
Toggle Summary NanoString to Present at the UBS Global Healthcare Conference
SEATTLE --(BUSINESS WIRE)--May 14, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 UBS Global Healthcare Conference .
View HTML
Toggle Summary Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research
Nature Biotechnology Publishes Comprehensive Description and Validation of the GeoMx Digital Spatial Profiler Using both nCounter & NGS Read Outs Multiple Studies Demonstrate the Superior Quantitative Performance of the GeoMx DSP in the Discovery of Predictive Biomarkers SEATTLE --(BUSINESS
View HTML
Toggle Summary NanoString to Present at the Bank of America Health Care Conference
SEATTLE --(BUSINESS WIRE)--May 11, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s management is scheduled to present at the 2020 Bank of America Securities Health Care
View HTML
Toggle Summary NanoString Technologies Releases Operating Results for First Quarter of 2020
SEATTLE --(BUSINESS WIRE)--May 7, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter of 2020. First Quarter Financial Highlights Product and service revenue of
View HTML
Toggle Summary Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
Scientists from the SingHealth Duke-NUS Academic Medical Centre in Singapore use Simplicity and Speed of nCounter to Publish Study Within Weeks of Infection NanoString Offers COVID-19 RNA Panel at no Charge for Research use Applications SEATTLE --(BUSINESS WIRE)--Apr.
View HTML
Toggle Summary NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
GeoMx DSP Orders and Revenue In-Line with Prior Guidance nCounter Instrument and Consumable Revenue Disrupted by COVID-19 SEATTLE --(BUSINESS WIRE)--Apr. 6, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today
View HTML